478 results on '"Kanki, Phyllis J."'
Search Results
2. HIV/AIDS Global Epidemic
3. Arbovirus surveillance in pregnant women in north-central Nigeria, 2019–2022
4. High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses
5. HIV/AIDS Global Epidemic
6. Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort
7. SARS-CoV-2 live virus culture and sample freeze-thaw stability
8. West African pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2
9. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa
10. Antiretroviral therapy retention, adherence, and clinical outcomes among postpartum women with HIV in Nigeria.
11. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
12. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions
13. The HIV-2 proviral landscape is dominated by defective proviruses
14. HIV-2: Lessons from the Dakar Cohort
15. Simian Immunodeficiency Virus (SIV) and HIV-2 (Retroviridae)
16. HIV/AIDS Global Epidemic
17. Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.
18. The HIV-2 proviral landscape is dominated by defective proviruses.
19. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions
20. Chikungunya virus antepartum transmission and abnormal infant outcomes in Nigeria
21. Arbovirus surveillance in pregnant women in north-central Nigeria, 2019-2022
22. SARS-CoV-2 live virus culture and sample freeze-thaw stability
23. Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection
24. Continued Transmission of Zika Virus in Humans in West Africa, 1992-2016
25. The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for COVID-19
26. Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study
27. Omnibus Tests for Comparison of Competing Risks with Adjustment for Covariate Effects
28. In vitro Correlates of HIV-2-Mediated HIV-1 Protection
29. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
30. Effects of selenium supplementation on pregnancy outcome and disease progression in HIV-infected pregnant women in Lagos, Nigeria: Study protocol for a randomised, double-blind, placebo-controlled trial
31. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
32. High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses
33. HIV/AIDS Global Epidemic
34. Infectious Diseases, Introduction
35. HIV Treatment Scale-up in Africa: The Impact of Drug Resistance
36. Biology of Human Immunodeficiency Virus Type 2 (HIV-2)
37. Monitoring Viral Load
38. HIV/AIDS Global Epidemic human immunodeficiency virus (HIV) global epidemic human immunodeficiency virus (HIV) Global Epidemic
39. Infectious Diseases infectious disease , Introduction
40. Declining Rate of Infection with Maternal Human Immunodeficiency Virus at Delivery Units in North-Central Nigeria
41. Intersectional Stigma and HIV Continuum Outcomes Among Sexual Minority Men in Sub-Saharan Africa: A Conceptual Framework
42. Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture
43. Human Immunodeficiency Virus Type 2 (HIV-2) : Biology and Pathogenesis
44. Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine
45. A Review of the Virological Efficacy of the 4 World Health Organization—Recommended Tenofovir-Containing Regimens for Initial HIV Therapy
46. Immunologie Criteria Are Poor Predictors of Virologie Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings
47. Relationship between Human Immunodeficiency Type 1 Infection and Expression of Human APOBEC3G and APOBEC3F
48. Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron Variant
49. The Absence of Anti-Tat Antibodies Is Associated with Risk of Disease Progression in HIV-2 Infection
50. SARS-CoV-2 Antigen Tests Predict Infectivity Based on Viral Culture: Comparison of Antigen, PCR Viral Load, and Viral Culture Testing on a Large Sample Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.